Company

Adularia

Biotechnology Research Zurich, Zürich, Ch 10 employees

Employees: 10
Contacts: 2
Emails: 2
Phones: 1

LinkedIn Crunchbase

Adularia Overview

Headquarters: Zurich, Zürich, Ch
Industry: Biotechnology Research
Employees: 10
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotech Therapeutics Immuno-oncology

About Adularia

At Adularia, our technology is rooted in the discovery of a potent immune mechanism, which is based on insights from the symbiotic interplay between gut microbes and the immune system. We have identified a novel therapeutic target for immune oncology through the discovery of a mechanism by which bacterial metabolites activate a potent anti-tumor immune reaction through activation of tumor-residing macrophages. By leveraging insights from natural metabolic processes, we develop small molecule therapies that enhance the body’s native immune response against cancer.

Adularia Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage
Phone contacts: 1; 33.3% coverage

Adularia Org Chart

Sample employees and titles

Name	Title	Location	Contact
Ana Montalban-Arques	CEO & Co-founder at Adularia		View
Dr. Martin Schwill	Head of Artificial Intelligence	Zurich, Switzerland	Email
Andrin Oswald	Health Care Executive	Switzerland	Email Phone